New drug gemini tested for kidney disease safety
NCT ID NCT06863467
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested a single dose of the experimental drug Gemini in 40 adults with stage 3 or 4 chronic kidney disease. The main goal was to check safety and side effects compared to a placebo. Researchers also measured how the drug moves through the body and its effect on inflammation and kidney function markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gemini (a phosphorylated hexaacylated disaccharide)
- What this could lead to
- If successful, this could point toward a new way to reduce inflammation and slow kidney damage in chronic kidney disease.
- What could go wrong
- This is a very early, small study focused on safety, not effectiveness. It may not show any benefit, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE3 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
California Institute of Renal Research
Chula Vista, California, 91911, United States
-
California Institute of Renal Research
La Mesa, California, 92942, United States
-
Clinical Advance Center, PLLC
San Antonio, Texas, 78212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?
- Kidney disease in young women: a hidden burden on fertility and future plans
- Why kidney disease drains your strength: scientists probe muscle fatigue
- Why kidney patients feel so tired: muscle fatigue under the microscope
- New drug combo aims to slow kidney failure in High-Risk patients
- Massive kidney study tracks 3,000 patients over 5 years